Announcements Trials
Browse Landscape

Phase

Phase 2 13Phase 3 11Phase 2/3 3Phase NA 2Phase 1 2Phase 4 1Phase 1/2 1

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Rectal Neoplasms 2Mouth Neoplasms 2Uterine Cervical Dysplasia 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Cancer Limited Stage 1Pancreatic Neoplasms 1Nasopharyngeal Carcinoma 1Head and Neck Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Advanced Solid Tumors 1

Interventions

Fluorouracil 38Capecitabine 31Oxaliplatin 30Leucovorin 30Radiotherapy 21Irinotecan 20Bevacizumab 15Radiation 12Cetuximab 12pembrolizumab 9Gemcitabine 7trifluridine tipiracil drug combination 5dehydroftorafur 5cediranib 5Radiotherapy, Intensity-Modulated 5Folfox protocol 5Erlotinib Hydrochloride 5Cisplatin 5Carboplatin 5trametinib 4Surgical Procedures, Operative 4Paclitaxel 4Neoadjuvant Therapy 4Gene Expression Profiling 4Cyclophosphamide 4sargramostim 3binimetinib 3Trifluridine 3Sorafenib 3Pemetrexed 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Rectal Neoplasms × Chemoradiotherapy × Clear all
NCT06300489 2024-03-08

Genotype-driven Weekly Irinotecan Liposomes in Combination With Capecitabine-based Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer

Zhejiang Cancer Hospital

Phase 1 Unknown
30 enrolled
Gastrointestinal

Rectal Neoplasms

NCT02277158 2014-12-02

Phase I Study of CCRT as Adjuvant Treatment for Stage II/III Operable Rectal Cancer.

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Phase 1 Unknown
18 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡